share_log

HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $58 Price Target

HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $58 Price Target

HC Wainwright & Co.重申买入Mirum Pharmicals,维持58美元的目标股价
Benzinga ·  05/09 06:38

HC Wainwright & Co. analyst Ed Arce reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and maintains $58 price target.

HC Wainwright & Co. 分析师埃德·阿尔塞重申米鲁姆制药公司(纳斯达克股票代码:MIRM)的买入并维持58美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发